Protein-Losing Intestinal Disease in Dogs (Protein-Losing Enteropathy, PLE)
- Occurrence: rarer
- Location of disease: General/Whole body
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Protein-losing enteropathy (PLE) in dogs is a condition where there is an excessive loss of proteins through the intestines, leading to a deficiency of important proteins in the blood.
BASICS/CAUSES:
Protein loss via the gastrointestinal tract results from a disturbed barrier function of the intestinal mucosa. This barrier is normally responsible for absorbing nutrients while simultaneously preventing harmful substances and excessive loss of essential nutrients. In PLE, however, there is an increased permeability of this barrier, which promotes the loss of proteins.
Various conditions can serve as the basis for PLE. The most common include inflammatory bowel disease (IBD), lymphangiectasia, and certain infections such as parasite infestations. Inflammatory bowel diseases lead to chronic inflammation of the intestinal mucosa, while lymphangiectasia involves a dilation of the lymph vessels in the intestine, which promotes protein loss.
Other causes can be neoplastic diseases (cancers) of the intestine, severe liver disease, or heart failure, which cause congestion of the blood vessels in the intestine, in turn increasing the permeability of the intestinal mucosa.
The most important facts at a glance
Protein-losing enteropathy (PLE) in dogs is a serious condition that can be caused by various intestinal diseases such as chronic inflammatory bowel disease, lymphangiectasia, or tumors. This condition leads to protein loss via the intestines, resulting in symptoms such as weight loss, loss of appetite, diarrhea, and edema. Diagnosis requires a thorough examination, blood tests to check protein levels, especially albumin, and imaging procedures. A biopsy of the intestinal mucosa may be necessary to identify the cause. Treatment is based on the underlying cause and often includes anti-inflammatory medications and dietary adjustments. A high-protein, easily digestible diet can help compensate for protein loss, while in cases of lymphangiectasia, a low-fat diet may be important. The prognosis depends on the cause and the response to treatment. Early detection and treatment can reduce the risk, while regular veterinary check-ups and a balanced diet promote overall health. Current research focuses on genetic predispositions, the role of the intestinal barrier, and the development of new therapeutic approaches, including special diets and the use of probiotics. Early diagnosis could be improved by identifying specific biomarkers, making access to early detection easier.
Causes
- Chronic inflammatory bowel disease (IBD)
- Lymphangiectasia (dilation of the lymph vessels)
- Intestinal lymphomas or other tumors
- Infections that damage the intestinal mucosa
Symptoms
The symptoms of PLE in dogs are often non-specific and can vary depending on the underlying cause. A common sign is chronic diarrhea, which is often accompanied by weight loss and reduced food intake. Since proteins are essential for maintaining body structure and function, affected dogs may also show signs of weakness and reduced urge to move.
Another noticeable symptom is the formation of edema or ascites (fluid accumulation in the abdominal cavity), which occur due to the low protein content in the blood. These fluid accumulations lead to swelling, particularly in the legs and abdominal cavity.
In some cases, Vomiting may also occur, especially if the underlying cause is inflammation of the stomach or upper small intestine.
Diagnosis
The diagnosis of PLE requires a thorough clinical examination, which is carried out together with a detailed medical history. Blood tests are crucial to detect low protein levels in the blood, especially albumin, which is most affected by PLE.
A fecal examination can help rule out parasitic infections, while imaging techniques such as ultrasound or X-ray are used to detect structural changes in the intestine or other organs. A biopsy of the intestinal mucosa may be necessary to identify the underlying cause, such as IBD or lymphangiectasia.
Additionally, specialized tests such as measuring triglyceride or cholesterol levels in the blood can be performed to support the diagnosis.
Therapy
The treatment of PLE aims to address the underlying cause while simultaneously relieving symptoms. For inflammatory bowel diseases, anti-inflammatory drugs or immunosuppressants may be prescribed to reduce inflammation.
Dietary adjustments are also important. A high-protein, easily digestible diet can help compensate for protein loss, while medium-chain triglycerides (MCTs) can be used as an energy source because they are more easily absorbed and put less strain on the lymph vessels.
In cases of lymphangiectasia, a low-fat diet may be recommended to minimize the strain on the lymph vessels. Water tablets or diuretics can be used to reduce excess fluid caused by edema or ascites.
Prognosis and follow-up care
The prognosis for dogs with PLE depends heavily on the underlying cause and the response to treatment. With early diagnosis and appropriate therapy, quality of life can be significantly improved, and some dogs can achieve long-term stabilization.
However, chronic cases or those that do not respond well to treatment are more difficult to manage. Komplications such as severe protein deficiency or secondary infections can further worsen the situation.
Prevention
Since PLE is often associated with a variety of underlying diseases, there is no specific preventive measure. Nevertheless, early detection and treatment of intestinal diseases can reduce the risk of PLE.
Regular veterinary examinations and a balanced diet can help promote the dog’s general health and reduce the likelihood of intestinal diseases occurring.
Special care should be taken in the selection of the diet and in avoiding stress-related factors that can increase the risk of inflammatory bowel diseases.
Outlook on current research
Protein-losing enteropathy (PLE) in dogs is a complex and serious medical problem that can be caused by a variety of gastrointestinal diseases. Current research efforts focus on better understanding the genetic predispositions and molecular mechanisms that lead to PLE. Researchers are particularly investigating the role of intestinal barrier function and how its impairment leads to increased protein loss. The findings from these studies could contribute to the development of new therapeutic approaches.
Another research focus is on identifying specific biomarkers that could enable early diagnosis. Currently, diagnostic procedures for PLE are often invasive and costly, which makes access to early detection difficult. By developing non-invasive diagnostic tests, dog owners and veterinarians could have better tools at their disposal to detect and treat the disease early.
Additionally, the role of nutrition in the treatment of PLE is being investigated. Researchers are working on developing special diets that minimize protein loss while maximizing the dog’s well-being. These studies could lead to tailored nutritional plans that are individually matched to the needs of dogs with PLE.
There are also ongoing studies looking into the use of probiotics and prebiotics to support intestinal health in dogs with PLE. The idea is that by improving the intestinal flora, the permeability of the intestinal wall and thus the protein loss could be reduced. Initial results are promising, but further research is needed to confirm the effectiveness and safety of such approaches.
Another interesting approach in current research is the investigation of the immune response in dogs with PLE. Some studies suggest that an excessive or misguided immune response could contribute to damage of the intestinal mucosa and protein loss. Research into specific immunomodulators could open up new treatment paths that specifically influence the immune system to alleviate disease symptoms.